Precision Optics Corp. (NASDAQ:POCI – Get Free Report) saw a significant decrease in short interest during the month of October. As of October 15th, there was short interest totaling 3,951 shares, a decrease of 90.2% from the September 30th total of 40,488 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 24,491 shares, the short-interest ratio is currently 0.2 days.
Analysts Set New Price Targets
Several research analysts have recently issued reports on POCI shares. Weiss Ratings restated a “sell (d-)” rating on shares of Precision Optics in a report on Wednesday, September 2nd. Wall Street Zen upgraded shares of Precision Optics to a “hold” rating in a research note on Saturday, October 3rd. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Precision Optics presently has an average rating of “Sell”.
Read Our Latest Report on POCI
Precision Optics Stock Performance
Shares of Precision Optics stock traded up $0.05 on Tuesday, hitting $4.40. The stock had a trading volume of 23,100 shares, compared to its average volume of 40,546. The stock has a market cap of $48.31 million, a price-to-earnings ratio of -9.57 and a beta of 0.34. The company has a current ratio of 2.28, a quick ratio of 1.84 and a debt-to-equity ratio of 0.03. Precision Optics has a 52-week low of $3.55 and a 52-week high of $6.15. The company’s 50 day moving average price is $4.41 and its 200 day moving average price is $4.62.
Precision Optics (NASDAQ:POCI – Get Free Report) last released its quarterly earnings results on Monday, September 28th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.05. Precision Optics had a negative return on equity of 23.92% and a negative net margin of 11.51%. The company had revenue of $8.77 million for the quarter, compared to analyst estimates of $7.10 million.
About Precision Optics
Precision Optics Corporation, Inc is a medical technology company that develops and manufactures advanced optical systems and components for minimally invasive medical procedures. The company works primarily with medical device manufacturers, providing specialized imaging technologies designed to support visualization during surgery and other clinical applications.
Its product portfolio includes rigid and flexible endoscopes, three-dimensional endoscopic systems, disposable and reusable visualization devices, surgical cameras, and custom optical assemblies.
Further Reading
- Five stocks we like better than Precision Optics
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
- Off-Price, High-Yield: Why Ross Stores Is Defying the Retail Slump
- Whirlpool’s Stock Collapse Raises a Bigger Question About Its Recovery Potential
Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.
